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Abstract
Background: In families segregating a monogenic genetic disorder with a single disease gene introduction, patients share a
mutation-carrying chromosomal interval with identity-by-descent (IBD). Such a shared chromosomal interval or haplotype,
surrounding the actual pathogenic mutation, is typically detected and defined by multipoint linkage and phased haplotype
analysis using microsatellite or SNP genotype data. High-density SNP genotype data presents a computational challenge for
conventional genetic analyses. A novel non-parametric method termed Homozygosity Haplotype (HH) was recently
proposed for the genome-wide search of the autosomal segments shared among patients using high density SNP genotype
data.
Methodology/Principal Findings: The applicability and the effectiveness of HH in identifying the potential linkage of
disease causative gene with high-density SNP genotype data were studied with a series of monogenic disorders ascertained
in eastern Canadian populations. The HH approach was validated using the genotypes of patients from a family affected
with a rare autosomal dominant disease Schnyder crystalline corneal dystrophy. HH accurately detected the ,1M b
genomic interval encompassing the causative gene UBIAD1 using the genotypes of only four affected subjects. The
successful application of HH to identify the potential linkage for a family with pericentral retinal disorder indicates that HH
can be applied to perform family-based association analysis by treating affected and unaffected family members as cases
and controls respectively. A new strategy for the genome-wide screening of known causative genes or loci with HH was
proposed, as shown the applications to a myoclonus dystonia and a renal failure cohort.
Conclusions/Significance: Our study of the HH approach demonstrates that HH is very efficient and effective in identifying
potential disease linked region. HH has the potential to be used as an efficient alternative approach to sequencing or
microsatellite-based fine mapping for screening the known causative genes in genetic disease study.
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Introduction
SNP genotyping technology is developing very rapidly. Phase II
of the International HapMap Project has characterized over 3.1
million single nucleotide polymorphisms (SNPs) with the resulting
SNP density of approximately one per kilobase [1]. High-density
SNP genotyping has gradually become a dominant data source in
molecular genetic and clinical laboratories. Illumina Infinium
Human1M-Duo and Human610-Quad Beadchips and Affymetrix
6.0 GeneChips are currently amongst the most advanced
genotyping platforms. The rapid advances in high-throughput
genotyping technologies require efficient methods which can fully
employ the profound information provided by the high-density
SNP genotype data.
High-density SNP genotype data presents a computational
challenge for genetic analyses. Disease gene mapping methods,
including linkage, haplotyping and association studies, identify
candidate regions containing a disease susceptibility gene by
exploiting the cosegregation of the disease phenotype and markers
in cases as well as the difference of allele sharing between cases and
controls. The determination of haplotype sharing may represent
the future direction of linkage analysis due to its better adaptation
to high-density SNP genotype data [2]. Tools that can make
efficient use of the profound information from high density SNP
genotype become increasingly important.
It is currently still difficult to obtain haplotype information
on a genome wide basis for high-density SNP genotype data
from either a general pedigree or a population. Performance of
haplotype inference methods in a general pedigree relies on
whether enough informative individuals have been genotyped.
Inference of haplotypes from a diploid population is a NP-hard
problem [3]. Many methods have been developed to recon-
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maximum-likelihood methods [5–8], phylogeny-based ap-
proaches [9,10], and other statistical methods [11,12]. Such
algorithms have been implemented in widely used linkage
packages including Vitesse [13], GeneHunter [14] and Sim-
walk2 [15]. However, for very large pedigrees combined with
large marker genotype data sets, analytical approaches quickly
become computationally intractable, and even sampling
methods such as Simwalk2 are computationally slow and
hardware-intensive. Thus the utility of likelihood based
approaches is still limited.
The non-parametric Homozygosity Haplotype (HH) method
(HH is not homozygosity mapping employed to search for
segments inherited homozygous by descent in inbred recessive
pedigrees) was proposed by Miyazawa et al. [16] recently for a
genome-wide search of shared autosomal segments with high
density SNP genotype data for families or genetically isolated
populations. Rather than formally phasing haplotypes, the HH
approach utilizes a reduced haplotype described by the
homozygous SNPs only. Homozygosity haplotype is easily
obtained by removing all heterozygous SNPs from a sample
data set. The reduced haplotype of each chromosome is then
uniquely phased by the string of the remaining homozygous
SNPs. For patients who inherited the same mutation from a
common ancestor, they share a chromosomal segment identical
by descent (IBD) around the disease susceptibility gene. For
both autosomal dominant and recessive inheritance, patients
should not have discordant homozygous calls in the IBD. In
HH, they share the homozygosity haplotype in the IBD interval.
An IBD segment is denoted as a region from a common
ancestor (RCA) in the HH approach. RCA is identified by
comparing the homozygosity haplotypes among patients. The
conventional haplotype analysis of phasing diploid alleles into
haploid alleles is greatly simplified by the idea of homozygosity
haplotype, which allows the HH program to perform genome-
wide analyses in minutes. However, the practical performance
and utility of the HH method have not been extensively
examined.
In this study, the applicability and the effectiveness of the HH
approach in localizing causative genes are presented and discussed
for a series of monogenetic disease projects with high-density SNP
genotype data. A large Canadian family with Schnyder crystalline
corneal dystrophy (SCCD, MIM 121800) for which the disease
susceptibility gene was discovered recently [17–19], was used to
validate the HH approach. We further tested the HH method for
identifying potential linkage to known genes in novel families or
cohorts. When a genetic disease is diagnosed, screening known
causative genes is an important procedure to provide further
clinical service. As one often finds when searching a phenotype in
the Online Mendelian Inheritance in Man (OMIM) database [20],
a disease phenotype is often linked to multiple genes or loci.
Sequencing and analyzing known genes is still time-consuming,
especially when the detected variants have not been published
before. Microsatellite genotyping is often used to detect linkage of
known loci. Genotyping with microsatellites are more labor
intensive and require more detailed analysis in calling the
genotypes. Assuming that patients who have inherited a
susceptibility gene from a common ancestor also share a haplotype
in the genomic interval, the HH approach can be applied to screen
the known causative genes or loci by searching for the shared
homozygosity haplotype. We show that HH mapping correctly
identifies the causal locus for a retinal degenerative disorder, and
excludes linkage to known genes for a cohort with a novel renal
failure phenotype.
Results
Validation of HH using a large family with SCCD
Schnyder crystalline corneal dystrophy (SCCD, MIM 121800)
is a rare autosomal dominant disease characterized by progressive
opacification of the cornea resulting from the local accumulation
of lipids, and associated in some cases with systemic dyslipidemia.
A large multigenerational family (Fig. 1) in Nova Scotia was
ascertained with SCCD. Previously published genetic analyses in
other families suggested linkage of SCCD to an interval on
chromosome 1. Intensive microsatellite fine mapping on 37
informative members of our family confirmed linkage to this
interval, refining it to 1.3 Mbp. The underlying causative gene,
UBIAD1, was identified by sequencing genes of the interval [17].
We utilized the SCCD family to test whether the HH algorithm
could correctly identify the causal locus.
Samples from 10 affected individuals were genotyped with
Illumina HumanHap550 chips. The HH program was first run
with the genotypes of all 10 patients with a cutoff value of 3.0 cM,
which is the recommended cutoff of HH approach [16]. Within
one minute, HH analysis identified a single RCHH (Region with
conserved HH) on chr1: 10,686,402–11,639,887 bp with a total of
175 informative SNPs and an interval size of 953,486 bp (Fig. 2a).
This chromosomal region correctly includes the causative gene
UBIAD1. The defined interval is smaller than the 1.3 Mbp
interval identified previously by fine mapping with customized
microsatellites [17], or the 2.32 Mbp region reported by
Theendakara et al. [21], indicating superior resolution of the
dense SNP marker panel in this instance.
We next sought to determine whether it was necessary to
include all 10 patients in order to identify the correct locus in this
pedigree. According to equation (1), the ratio of RCA shared by
patients decreases with the number of generations removed from
their common ancestor. Therefore, samples from the youngest
generation of different family branches should be more informa-
tive in general. By selecting samples according to this rule, subject
1351 and 1425 (m+n=10) were selected first, and the HH analysis
result is shown in Figure 2(b). Patients 1351 and 1425 shared a few
other large RCHHs in addition to the largest interval at chr1:
3,539,057–11,973,221 with a size of 8.4 Mbp. Thus two affected
subjects were insufficient to determine a unique genomic location
of the causal locus. By next adding most distantly related
individual, 1438, only two RCHHs were left (Figure 2(c)), and
the largest RCHH on chromosome 1 decreased to 0.9 Mbp. The
second, incorrect RCHH on chromosome 17 could be excluded
by adding any one genotype of other affected individuals. As
shown in Figure 2(d), the only RCHH shared by the four
individuals 1351, 1425, 1438, and 1349 is the same interval as the
one identified using 10 samples. This study of sample subsets
demonstrates that the optimal genotype data set for HH analysis
should be those from the youngest generation or otherwise most
distantly related affected individuals in a pedigree.
Application of HH to identify the disease linked region
for a family with retinal degeneration
Although affected individuals are the most informative for non-
parametric analysis, the statistical functions of HH (see equa-
tion (2) and (3)), which were developed to study multigene diseases
using genotypes of both patients and controls, can be extended to
include unaffected family members. This is similar in spirit to a
family-based association approaches [22–24]. In general, the test
statistics for association analysis may be regarded as a test for the
presence of a difference in allele frequency between cases and
HH and Genetic Mapping
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unaffected members of a family as cases and controls respectively.
We ascertained a large Canadian family with a specific
pericentral retinal disorder (PRD) (Fig. 3). Thirty-four family
members were genotyped with the Illumina HapMap300
beadchip with a total of 318,237 SNPs. We first performed HH
analysis using genotypes of eight definitively affected family
members only, with a pairwise cutoff value of 3.0 cM to search
the candidate RCHHs. As shown in Fig. 4a, the affected-only
analysis identified two large RCHH regions. One was on
chromosome 3 at 128–134 Mbp, the other on chromosome 6 at
151–161 Mbp. We then performed the HH statistical analysis
using both the patient pool and the control pool (Fig. 4b). Of the
two RCHH regions previously defined by affecteds only, the
physically larger region on chromosome 6 lost significance.
Whereas the region at chr3: 128,295,267–133,701,313 became
the most significant candidate locus with the largest 2log10
P value
of 3.35. The region was confirmed later by the whole genome scan
results of two point and multipoint linkage analyses. Two point
linkage analysis was carried out using the MLINK routine of
FASTLINK v4.1P [25,26] with a dominant transmission model:
Penetrance of 0.95, phenocopy of 0.001, and the disease allele
frequency of 0.001. Two point linkage identified 6 regions with
LOD scores .3.0 (Fig. 5a). The extended interval on chromosome
3 was the most consistent one. Multipoint linkage analysis was
carried out using SIMWALK2SNP [15,27,28] version 2.91 with
the same dominant transmission model. Tag SNPs were selected
from the 6 regions using Haploview [29] for multipoint linkage
analysis. The chromosome 3 interval was identified with the
highest LOD score 2.15 of all tested intervals (Fig. 5b). The region
encompasses the gene encoding rhodopsin. A missense mutation in
rhodopsin was detected by direct resequencing as the presumptive
causative mutation in the pedigree. These results demonstrate that
the HH approach can be effectively applied to study monogenic
traits in large families by utilizing the genotypes of both affected
and unaffected family members.
Application to the screening of known causative genes
The whole-genome screening approach was further validated
using a Canadian family ascertained with myoclonus dystonia
(MIM 159900). Three causative genes are known for this genetic
condition: SGCE [30], DRD2 [31], and DYT1 [32]. Direct
sequencing concurrent with our analysis identified a null mutation
in the SGCE gene in affecteds from this family. We tested whether
the HH approach could exclude non-causative genes correctly.
Four patients from the family were genotyped with the Illumina
HumanHap550 beadchips. HH was run first to identify RCHHs
shared among the four patients with a cutoff of 3.0 cM. The
RCHHs are given in Table 1, and the genome-wide mapping of
RCHHs is shown in Fig. 6. The largest RCHH at
chr7:93,168,493–130,965,632 with size of 37 Mb includes gene
SGCE (chr7:94,052,472–94,123,457). No RCHH was found
around the DRD2 (chr11:112,785,527–112,851,211) or DYT1
(chr9:131,616,072–131,626,199) genes. The genotypes of the
genomic regions with DRD2 and DYT1 inside were further
analyzed to examine the effect of genotyping errors on their
exclusion. The genotyping error simulation method (see Methods)
was applied to calculate the reliability of genotype data, the results
are shown in Table 2. The discordant homozygous SNPs (dhSNPs)
of the original genotypes in the regions were permutated to
concordant SNPs. MC simulation was run 10,000 times on the
transformed genotype data with both error model 1 and 2 and a
high error ratio of 0.01. The distributions of the number of
dhSNPs produced by the simulated genotyping errors were then
Figure 1. Pedigree of a family with Schnyder crystalline corneal dystrophy. Genotyped subjects are 1351, 1349, 1429, 1438, 1455, 1425,
1421, 1440, 1448, and 1437.
doi:10.1371/journal.pone.0005280.g001
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PLoS ONE | www.plosone.org 3 April 2009 | Volume 4 | Issue 4 | e5280Figure 2. Identification of the candidate regions for the family with Schnyder crystalline corneal dystrophy using HH approach. (a)
RCHHs shared by 10 patients. The RCHH intervals are shown in black. Other autosomal regions are shown in grey as background. (b) RCHHs shared by
1351 and 1425. (c) RCHHs shared by 1351, 1425, and 1438. (d) RCHH shared by 1351, 1425, 1438, and 1349.
doi:10.1371/journal.pone.0005280.g002
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Based on the obtained distribution, the P values are all
approximately 0. The simulation results suggest that the dhSNPs
in the original genotype used to define RCHH are reliable.
Consequently, the DRD2 and DYT1 genes were excluded with
high confidence. Thus the HH approach correctly interpreted
unlinked candidate genes, and identified the potential linkage of
SGCE in the meanwhile.
The selection of the cutoff value and samples is critical in
employing the HH method. We used a family we ascertained with
generalized renal failure as an example to illustrate the selection
procedure. Four patients S1, S2, S3, and S4 from the family (Fig. 8)
were genotyped with Illumina HumanHap550k beadchips. We
tested for linkage of the family to either of two known causative
genes for related renal conditions: PKD1 (chr16:2,078,712–
2,125,900) and PKD2 (chr4: 89,147,844–89,217,952). HH
analyses of the four affected samples taken together showed they
do not share RCHH covering the two genes.
The genotyping error simulation method was applied to study
the error possibilities using 550k genotype data of two affected
subject s1 and s4. The Monte Carlo simulation of genotyping error
was run 10,000 times for each test. As shown in Table 3, the P
values are all lower than 0.001. As a consequence, PKD1 and
PKD2 could be confidently excluded as causal for the phenotype
in this family, which is now undergoing further mapping to
identify a linked causal locus. To demonstrate the selection of
cutoff value and samples, the results of HH analyses with different
subsets of the four genotyped subjects and different RCHH cutoff
values are shown in Table 4. PKD1 and PKD2 could not be
excluded when using closely related sample subsets, e.g. S1-S2
(m=1, n=1), or S2-S3 (m=2, n=2). However, all subsets with
more distantly related patients, including S2-S4 (m=3,n=3) and
S3-S4 (m=3,n=3), were successful in ruling out the PKD1 and
PKD2 genes as compared to the full analysis using all four
samples. The results show that the selection of more distantly
related samples would give a higher success rate for the screening
of known causative genes. In addition, the performance of
screening can be improved by adding more genotype data of
affected individuals. For cutoff value selection, the HH analyses
with a small cutoff of 1.0 cM were not able to exclude PKD1 and
PKD2 when the patients were more closely related, e.g. subset S1-
S2, S2-S3 and S1-S3. For the two descendants / patients from a
family with 2#m+n#6, a condition suitable for a general family, a
cutoff of 2.0 cM is recommended for the screening of known
causative genes because the ratio of type II errors in identifying
candidate region to the total length of the RCAs is lower than 0.01
[16]. When the subjects are too closely related, e.g. an affected sib
pair with m+n=2, it is suggested to genotype more affected
individuals.
Impact of SNP genotyping errors on HH analysis
As other statistical genetics methods, the accuracy of HH
approach is also affected by genotyping errors. Genotype errors
may impact HH results in two ways. Genotype errors may break
down a large RCHH to a few smaller RCHHs or intervals, and
make the RCHH undetectable if the intervals are smaller than the
cutoff value. Second, genotype errors may create a false RCHH.
An interval with discordant homozygous SNPs can be identified as
a false RCHH if all the discordant SNPs are changed to
concordant SNPs by genotyping errors.
For the first possible impact, a genotype error must change a
non-dhSNP (either a non-comparable SNP or a matched
comparable SNP) to a dhSNP (a mismatched comparable SNP).
For a non-dhSNP, when at least one sample is homozygous for the
SNP, there is a half chance to cause an error if an AB call was
changed to AA or BB. Whereas the change of a homozygous call
AA or BB to AB has no effect, the changing to the opposite
homozygous call will cause an error only if other homozygous calls
of the tested samples are also present. Given an error ratio E, the
chance of generating a false dhSNP by genotype error is #E/2.
For the second potential impact, genotype errors may create a
false RCHH by changing all dhSNPs of an interval to non-
dhSNPs. Given an error ratio of E, an interval with total NdhsNP of
dhSNPs for two samples, the chance of creating a false RCHH
by genotype errors is ENdhSNP. The possibility would be lower when
using multiple samples because either all AA or all BB calls should
be changed by genotyping error. The possibility of generating false
RCHH by genotype errors is apparently very low. Therefore, the
major impact of genotype errors on HH analysis is to break down
a large RCHH.
Discussion
In this study, we investigated the applicability and the
effectiveness of HH in identifying genetic disease genes with a
series of monogenetic disorders ascertained in eastern Canadian
populations. We applied HH to identify the known locus using the
genotypes of 10 affected subjects of a family with a rare dominant
eye disease SCCD. HH analysis successfully detected the 1 Mb
shared segment of the affected members with a minimum of four
Figure 3. The pedigree of a family with a progressive retinal degenerative disorder. Genotyped individuals are indicated with red circles
(affected) and blue circles (unaffected).
doi:10.1371/journal.pone.0005280.g003
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optimal genotype data set for HH analysis should be those from
the youngest generation or otherwise most distantly related
affected individuals in a pedigree. This suggests that important
upstream efficiencies can be realized in the clinical phase of
genetic studies by the adoption of a sparse recruitment strategy
focused on the most informative individuals. We also explored the
applicability of HH to the family based case and control study.
Thirty-four family members from a large Canadian family with a
specific retinal disorder PRD were genotyped with the Illumina
HapMap300 beadchip. With 13 affected samples in the patient
pool and 19 samples in the control pool, HH identified an RCHH
on chr3 with the lowest P value. The interval was confirmed by the
two point and multipoint linkage analyses, and for which the
causative mutation was found by direct resequencing. Clearly the
HH approach can be effectively applied to study monogenic traits
in large families by utilizing the genotypes of both affected and
unaffected family members. HH can also be applied to test known
causative genes or loci quickly for potential linkage. The whole-
genome screening approach was further validated using a
Canadian family ascertained with myoclonus dystonia and a renal
failure cohort. HH correctly detected the potential linkage of
myoclonus dystonia, and excluded the known causative genes for
the renal failure cohort. These applications demonstrate that HH
is an efficient and reliable tool in identifying the potential linkage
for monogenic diseases. In addition, the successful application of
HH to our projects indicates that HH is well suited for founder
populations like those in Atlantic Canada. The population is
Figure 4. Using HH method to identify the candidate regions with both cases and controls for the family with progressive retinal
degenerative disorders. (a) RCHH mapping using the 300K SNP genotypes of eight affected individuals 312, 317, 318, 326, 329, 335, 349, and 360.
The RCHH intervals are shown in black. Other parts of autosomes are shown in grey as background. (b) Densitogram of 2log10
(P) value for the
representative RCHHs shared by patients with the unaffected individuals as controls. The darker the color, the more significant the RCHH is. HH
analysis was run using affected family members as cases, unaffected family members as controls. The subjects used to build the patient pool were
312, 317, 318, 326, 329, 334, 335, 342, 348, 349, 358, 359, and 360, in which 334 and 358 were subsequently re-diagnosed as suspicious unaffected.
Samples in control pool were 276, 277, 309, 310, 314, 315, 328, 330, 331, 332, 333, 336, 344, 352, 353, 355, 356, 357, and 362.
doi:10.1371/journal.pone.0005280.g004
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PLoS ONE | www.plosone.org 6 April 2009 | Volume 4 | Issue 4 | e5280Figure 5. Linkage analysis results for the family with progressive retinal degenerative disorders. (a) Whole genome scan 2-point linkage
result. (b) Multipoint linkage result on chromosome 3.
doi:10.1371/journal.pone.0005280.g005
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thousands of ancestors with m=n=20.
The HH approach is very efficient and easy to implement. In
comparison to other linkage analysis programs, the most
significant advantage of HH is its high computational efficiency.
The time complexity of HH algorithm is O(n
2). It was reported that
the calculation for a family with Marfan syndrome that contains
nine subjects is completed in 6 s on a laptop, and another analysis
composed of two pools containing 45 subjects each took 5 min
[16]. All the HH analyses performed in this study were finished in
less than one minute on a computer station with Intel Xeon
3.2 GHz processor. HH analysis can be run on personal
computers. Additionally, HH is easy to implement and use. HH
can be run on Mac with graphical user interface. Most of the work
in implementation involves generating the proper input genotype
data format and the annotation file for a particular SNP chip. HH
is a non-parametric method. Hence there is no need to specify a
complete genetic model. When HH is applied to study a large
family affected with a genetic disease, it is usually not necessary to
genotype many family members because more distantly related
subjects are theoretically more informative in HH analysis. One
may start by genotyping several affected subjects from the
youngest generation, subsequently narrowing the RCHH down
by adding more subjects to the analysis as required.
One feature of the HH method that can be improved is the
usage of cutoff value. In our applications, we found it difficult to
determine an optimal cutoff value. A cutoff value of 3.0 cM was
used by the Miyazawa et al. [16]. In general, there is a tradeoff
between the size of the cutoff value and the ability to correctly
define a single truly linked locus. Miyazawa et al. [16] have
discussed extensively the relationship of cutoff values and the
type I and type II errors in identifying candidate regions. The
average genetic length of the RCAs decreases over generations.
Therefore, more distantly related subjects tend to share smaller
RCA and a smaller cutoff should be used. One possible solution is
running the analyses by gradually reducing the cutoff value until
an RCHH appears. Sometimes a cutoff value 3.0 cM will not
identify any RCHH. On the other hand, the results obtained
using a smaller cuttoff value of 1.0 cM can have many
undistinguishable false positives. The problem can be partly
solved if a significant RCHH can be identified by adding
unaffected subjects as controls. In case no controls can be used, it
is an issue if there are multiple RCHHs without significant
differences in size.
In this study, we analyzed the impact of genotype errors on HH
analysis. The major impact of genotype errors on HH analysis is
breaking down a large RCHH. Several approaches may be useful
to reduce the impact of genotype errors. Miyazawa et al. [16] used
Table 1. List of RCHHs shared by the four patients from a Canadian family ascertained with myoclonus dystonia.
SNPs Chromsome Start(SNP) Start(bp) End(SNP) End(bp) Size(bp)
6193 7 rs10243929 93,168,493 rs929731 130,965,632 37,797,140
5156 15 rs12443212 31,309,577 rs11855284 56,476,479 25,166,903
4987 6 rs6914928 95,181,973 rs9398707 123,268,276 28,086,304
3814 1 rs17095322 74,676,941 rs957334 94,801,569 20,124,629
3041 17 rs17644943 62,338,082 rs1622986 75,438,157 13,100,076
2677 4 rs1910739 52,378,364 rs17652284 68,905,652 16,527,289
2534 1 rs12095738 165,746,611 rs2609473 179,602,130 13,855,520
2063 4 rs2911902 37,467,034 rs1051447 48,758,629 11,291,596
1977 11 rs11024074 16,873,795 rs4465366 24,639,693 7,765,899
1915 6 rs7753334 10,403,729 rs214582 18,324,763 7,921,035
1668 2 rs7576924 56,355,325 rs3919602 65,890,044 9,534,720
1234 14 rs4900132 92,029,991 rs8019939 95,934,062 3,904,072
1044 4 rs1878519 8,161,682 rs7688193 13,344,993 5,183,312
962 1 rs2995381 239,115,984 rs6656693 243,402,266 4,286,283
916 7 rs160346 28,532,166 rs917749 31,761,680 3,229,515
786 1 rs10925300 235,283,523 rs1982530 238,365,440 3,081,918
738 1 rs2051086 49,877,788 rs1469344 55,158,755 5,280,968
708 4 rs4694317 71,386,025 rs4859537 76,745,685 5,359,661
668 6 rs10945617 159,872,422 rs1790004 162,302,229 2,429,808
546 6 rs2148943 20,254,160 rs1047953 22,294,843 2,040,684
359 1 rs3767514 199,383,756 rs2741853 200,672,294 1,288,539
346 3 rs11131140 8,650,778 rs2479 9,883,525 1,232,748
327 10 rs11017516 132,538,433 rs7084312 133,703,278 1,164,846
235 20 rs1892318 59,421,464 rs6089695 60,241,421 819,958
204 21 rs914238 45,840,089 rs9979962 46,792,735 952,647
180 18 rs6506336 5,833,069 rs11873891 6,495,597 662,529
62 6 rs1891086 22,330,108 rs4560628 22,559,799 229,692
doi:10.1371/journal.pone.0005280.t001
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confidence. Checking Mendelian inconsistencies can remove some
of the errors if the genotyped samples are suitable for running a
Mendelian test. However, 100% of errors can not be excluded.
Hao et al. [33] studied the genotype errors of GeneChip Mapping
10k array, and found that the average genotyping error rate of this
SNP genotyping technology was about 0.1%. Illumina reported
that the rate of Mendelian inconsistencies of Illumina Human-
Hap550 beadchip is 0.06% [34]. Genotyping errors may or may
not cause Mendelian inheritance incompatibilities, SNP genotyp-
ing error-detection rates have been studied using trio designs, and
it has been estimated that Mendelian incompability errors in
theory may detect no more than 61% of all possible errors [35,36].
The difference between the true and the estimated error rates is
mainly due to errors that are ‘Mendelian compatible’ [37]. As a
consequence, it is estimated that the average genotyping error rate
of the 550k SNP genotyping is close to 0.1%. But the actual error
rate usually varies for different batch of data. The error simulation
method presented in this study, in which a high error ratio of 1.0%
was selected to simulate the effect of potential genotyping errors
under the worst situation for the purpose of screening known
genes, could be an alternative solution.
Conclusions
Our study of the HH approach with Illumina high-density SNP
genotype data from a series of Atlantic Canadian monogenetic
disease projects demonstrates that HH is very efficient and
effective in identifying disease linked and unlinked regions. The
method can be used as an efficient alternative approach to
sequencing or microsatellite-based fine mapping for the research
and clinical diagnosis of genetic diseases.
Methods
Important concepts of HH method
HH. An HH is a haplotype described by only homozygous
SNPs. It is obtained by deleting heterozygous SNPs. Then, the
haplotype of each chromosome is uniquely determined by the
combination of the allelic type in each homozygous genotype.
Comparable SNP. A comparable SNP is a SNP that is
homozygous in two subjects. HH can be compared between two
subjects using the comparable SNPs. The mismatched comparable
SNP has discordant homozygous SNP genotypes in two subjects,
one is AA and the other is BB. We used dhSNP (discordant
homozygous SNP) to represent the mismatched comparable SNP.
Figure 6. Screening of the three known causative genes DRD2, DYT1, and SGCE for a Canadian family with myoclonus dystonia
using HH approach and the genotypes of four patients.
doi:10.1371/journal.pone.0005280.g006
Table 2. The error possibilities calculated using genotyping error simulation method in the screening of the known causative
genes for a family with myoclonus dystonia with the genotype data of four affected individuals.
Gene Region NSNP NdhSNP Error Model1 Error Model2
E=0.01 t=0.005
DRD2 Chr11:111,851,211–113,785,527 493 77 l=8.98 l=4.24
P=0 P=0
DYT1 Chr9:130,626,199–132,616,072 480 72 l=8.76 l=5.05
P=0 P=0
doi:10.1371/journal.pone.0005280.t002
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matched comparable SNPs with genetic length longer than a
cutoff value. A RCHH is bounded by either dhSNPs or by the
ends of the chromosome. HH approach searches RCHHs between
each pair of subjects. The overlapped RCHH shared by multiple
subjects is used to predict the presence of region of conserved
ancestry (RCA) or identity by descent (IBD).
RCA sharing. For the two descendants with m and n
generations removed from a common ancestor, the ratio of the
total genetic length of the derived RCA to the entire length of the
autosomes is denoted as RCA(m,n), which can be calculated with
RCA m,n : m§n ðÞ ~
2{mz1
3=4
2{m{nz2
m§1, n~0
m~1, n~1
otherwise
8
> <
> :
9
> =
> ;
ð1Þ
Statistics in using patient and control pools. The HH
program also has a statistical method developed to identify
candidate regions for multigene diseases in genetically isolated
populations by comparing the shared RCHHs between the
patient pool and the control pool [16]. In the algorithm, an
autosomal interval is firstly divided into minute regions. The
RCHH shared by the largest number of patients in the patient
pool is then selected as the representative RCHH for each small
region. After that, the numbers of subjects who share the
representative RCHH were counted for both the patient pool
and the control pool. Finally, the significance of each
representative RCHH is calculated. The numbers of subjects
who share an RCHH at a given position on an autosome were
compared between the patient pool and the control pool. The
assumption was made that
u0 ~
P 
1{P 
2 ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
^ P P  1{^ P P    
1
n1 z 1
n2
   r ð2Þ
has a standard normal distribution, where ^ P P 
1 ~
x1 z 0:5
n1z1
,
^ P P 
2 ~
x2 z 0:5
n2z1
, ^ P P  ~
x1 z x2z 0:5
n1 z n2 z 1
, x1 and x2 are the
numbers of subjects sharing RCHHs in the patient pool and
the control pool, respectively, and n1 and n2 are the total numbers
of subjects in the patient pool and the control pool, respectively.
The significance of each representative RCHH is expressed with
the P value, which is calculated by
P ~
ð?
u0
1
ﬃﬃﬃﬃﬃﬃ
2p
p e{x2
2 dx ð3Þ
Figure 8. Pedigree of a family with renal failure.
doi:10.1371/journal.pone.0005280.g008
Figure 7. Histogram distribution of the dhSNPs introduced by
genotyping error. Error simulation was performed on the genotype
data of Myoclonus dystonia patients in region Chr11:111,851,211–
113,785,527 including DRD2 gene. The curve is the fitted Poisson
distribution curve with l=8.98 (s=0.03). Genotyping error was
simulated using error model 1 with an error ratio 0.01. Monte Carlo
error simulation was run 10,000 times.
doi:10.1371/journal.pone.0005280.g007
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Samples were genotyped with the Illumina HumanHap300K or
HumanHap550K SNP genotyping beadchips. The Illumina
HumanHap300 chip has a total of 318,237 SNPs, and the
HumanHap550K genotype has a total of 561,466 SNPs.
Genotype data of subjects were transformed to the input format
of HH program.
Implementation of HH
The source code of HH program [16] was obtained from the
author. The source code was modified to customize the output
format of the RCHH list. The revised C source code of the HH
program was compiled with GNU compiler on a Linux-based
operating system Fedora. The parameter LARGEGAP defined in
the header file, which is used to define large gaps like centromere,
was changed from the default value of 300,000 bp to 400,000 bp
to accommodate some non-centromere spaces between two
consecutive SNPs. The SNP annotation file provided by HH
software is for the Affymetrix 500K GeneChips Human Mapping
Array Set. Annotations of SNPs include fields of SNP name,
physical coordinates, genetic distances, and minor allele frequen-
cies. The annotation files for Illumina HumanHap300K and
HumanHap550K SNP genotype were created according to the
requirement of the HH program with the SNP annotations
downloaded from Illumina technical support ftp site. The genetic
distances of SNPs with empty value, inconsistent value, or zero
were interpolated according to the physical coordinates of their
flanking SNPs. The SNP annotations for CEU population were
used in this study.
Method of genotyping error simulation for the screening
of known causative genes
Genotyping Error Model. Two commonly used error
models were implemented. Genotyping error was introduced
randomly in the SNP genotypes of each individual with a given
error rate.
Model 1. The model was first introduced by Lincoln and
Lander [38], which is widely used [39–41]. The model assumes a
uniform distribution of errors over the available genotypes at a locus.
For SNP genotype, the penetrance function of genotyping error is
Po jG ðÞ ~
1{E,
E=2,
o~G
o=G
  
In which, o is the observed genotype of a SNP, G is the underlying
genotype, the genotype error rate is e. The error rate is the same for
all possible underlying genotypes.
Model 2. This model uses mean error rate per allele to
quantify genotype errors [33,35,37]. In the random error model, it
is assumed that the average probability of misclassifying allele A or
B to B or A is equal, which can be denoted as
PAB j ðÞ ~ PBA j ðÞ ~ t:
In which, t is the allelotyping error rate. Thus, the penetrance of
error genotype follows
PA BA A j ðÞ ~ PA BB B j ðÞ ~ 2t { 2t2,
PA AA B j ðÞ ~ PB BA B j ðÞ ~ t { t2,
and
PA AB B j ðÞ ~ PB BA A j ðÞ ~ t2:
t can be approximated to E/2 when t is small [33].
Table 3. The error possibilities calculated using genotyping error simulation method in screening known causative genes PKD1
and PKD2 for a family with renal failure with the genotype data of patient s1 and s4.
Gene Region NSNP NdhSNP Error Model1 Error Model2
E=0.01 t=0.005
PKD1 Chr16:1,125,900–3,078,712 277 9 l=1.72 l=0.79
P=7.73e–5 P=1.60e–7
PKD2 Chr4:88,217,952–90,147,844 388 15 l=2.47 l=0.98
P=5.81e–8 P=2.17e–13
doi:10.1371/journal.pone.0005280.t003
Table 4. The effect of using subsets of the affected
individuals (s1, s2, s3 and s4) and different cutoff values in the
screening of the known causative genes PKD1 and PKD2 for a
family with renal failure.
Samples Cutoff 1.0 cM Cutoff 2.0 cM Cutoff 3.0 cM
PKD1 PKD2 PKD1 PKD2 PKD1 PKD2
s1, s2; m=1,n=1 22+ 2 + 2
s2, s3; m=2,n=2 2 + 2 +++
s1, s3; m=2,n=2 22++++
s1, s4; m=3,n=3 2 +++++
s2, s4; m=3,n=3 ++++++
s3, s4; m=3,n=3 ++++++
s1, s2, s3 2 +++++
s1, s2, s4 ++++++
s2, s3, s4 ++++++
s1, s3, s4 ++++++
s1, s2, s3, s4 ++++++
‘+’ indicates no RCHH shared by patients is found flanking the gene, and
suggests the gene is excludable; ‘2’ indicates an RCHH is found flanking the
gene. m and n are the number of generations of the two patients descended
from their common ancestor.
doi:10.1371/journal.pone.0005280.t004
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down if genotyping errors change non-dhSNPs to dhSNPs.
Furthermore, the RCHH will not be identified if the resulted
segments are smaller than the cutoff in genetic distance. As a
result, the causative gene will be excluded mistakenly because of
the impact of genotyping error. To investigate the possibility of this
type of error, Monte Carlo (MC) simulation was used to simulate
the influence of genotyping error.
First, the genotype of all tested samples in the region with a
known causative gene was modified by replacing the dhSNPs with
non-dhSNPs; thus the modified genotypes had consistent homo-
zygosity haplotype. Given a gene/loci at chrN with start position
at P1(bp) and stop position at P2 (bp), the region with a known
gene/loci is defined as on chrN, starting at P2-1.0 Mb, and ending
at P1+1.0 Mb. Then, the MC simulation was performed on the
modified genotypes with the selected genotyping error model and
error rate. After a large number of runs of MC simulation on each
individual’s genotype, the distribution of the number of dhSNPs
created by genotyping errors was analyzed using the Poisson
distribution with the probability density function in equation (4).
The Poisson distribution is discrete, and has only a single
parameter l that is both the mean and the variance.
Pr Y ~ k l j fg ~
e{ll
k
K!
for k ~ 0,1,2,... ð4Þ
The possibility of the observed dhSNPs generated by genotyping
error was calculated according to equation (5). The P value, the
possibility of getting N number of dhSNPs generated by
genotyping error in a region without dhSNPs is
Pr Y § N l j fg ~ 1{
XN{1
k~0
e{ll
k
k!
: ð5Þ
The error simulation results, i.e. the number of dhSNPs for each
run, can be imported to R [42] to calculate the possibility of
getting N number of dhSNPs by genotyping error. If the possibility
is very low, e.g. P,0.001, that is, the dhSNPs in the region are not
likely created by genotyping error. Consequently, the genotype
and HH results are reliable.
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